搜索并找到您需要的 CMO / CDMO
为您的药物开发和制造项目寻找高技能合作伙伴。
受控物质: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse
市场: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), EDE (UAE), TGA (Australia)
服务: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
地区: 欧洲
遵守: FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), NMPA (China GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)
批量大小: Large, Small, Medium
使用: Human, Veterinary
专业治疗领域 (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (A) Digestive tract and metabolism
类别/产品: FDF / 药品
OEB(职业暴露带): 1 / low-hazard (PDE > 10,000 µg/day)

受控物质: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse
市场: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), ANVISA (Brazil), Russian Health Authorities, MHRA (UK), MFDS (South Korea), TGA (Australia)
地区: 欧洲
遵守: FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), NMPA (China GMP), EMA (EU GMP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)
使用: Human
服务: Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
专业治疗领域 (ATC): (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (N) Nervous system, (A) Digestive tract and metabolism
OEB(职业暴露带): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
批量大小: Small, Medium
类别/产品: FDF / 药品

OEB(职业暴露带): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
BSL(生物安全等级): 3, 4, 1, 2
受控物质: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
市场: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), TGA (Australia)
地区: 欧洲
遵守: FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), TGA (Australia GMP), NMPA (China GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)
批量大小: Large, Small, Medium
使用: Human, Veterinary
服务: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
专业治疗领域 (ATC): (H) Systemic hormonal preparations excl. sex hormones and insulins, (L) Antineoplastic and immunomodulating agents, (G) Genito urinary system and sex hormones
类别/产品: FDF / 药品
市场: EMA (EU), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), ANMAT (Argentina), INVIMA (Colombia)
服务: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging
地区: 欧洲
遵守: BRCGS, ISO, IFS, World Health Organization (GMP / HACCP)
批量大小: Large, Small, Medium
类别/产品: 化妆品, 营养保健品
使用: Human
专业治疗领域 (ATC): (V06) Nutrients
OEB(职业暴露带): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day)
BSL(生物安全等级): 3, 4
受控物质: High potential for abuse & medical use
遵守: ICH, ISO, ANVISA (Brazil B-GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), NMPA (China GMP), EMA (EU GMP)
市场: EMA (EU), NMPA (China), ANVISA (Brazil), MHRA (UK), SFDA (Saudi Arabia), Turkish Health Authorities
服务: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
地区: 欧洲
批量大小: Large, Small, Medium
使用: Human
专业治疗领域 (ATC): (L) Antineoplastic and immunomodulating agents
类别/产品: FDF / 药品
化学合成 manufacturing site
MAI network supplier
制药 CRO/CMO
注册后可用位置
化学合成 manufacturing site
MAI network supplier
拥有全球认证的原料药及中间体制造商。
注册后可用位置
生物制剂 manufacturing site
MAI network supplier
符合 GMP 要求的生物制剂生产设施,专门生产重组酶和蛋白质。
注册后可用位置





